AstraZeneca vaccine: Indian volunteer pursues adverse effects in laboratories



[ad_1]

An Indian volunteer who conducted the trials of the vaccine produced jointly by the laboratory AstraZeneca and the Oxford University against COVID-19 sued for more than half a million dollars to the Indian responsible for carrying out the tests.

The coordination was in charge of the Serum Institute of India, an institution claimed by the volunteer, according to Indian media, for fifty million rupees, about 676 thousand dollars.

In addition to the amount of money, the volunteer also demanded that vaccine trials be stopped immediately in the rest of the 1,600 people in which it is applied.

Laboratories where the vaccine is produced by the University of Oxford and AstraZeneca.  Photo / AP

Laboratories where the vaccine is produced by the University of Oxford and AstraZeneca. Photo / AP

What happened to the Indian volunteer

The wife of vaccine volunteer AstraZeneca, whose identity has so far not been revealed, said the man received the first of two doses of the vaccine on October 1.

Everything started well because after the first application, they carried out a test eleven days later and where antibodies were detected in the body of the volunteer. This was the first confirmation that the man had received the vaccine and not a placebo.

Surveillance continued to record how tests of the immune system response developed.

The complainant’s wife recounted that at one point her husband started to have a severe headache, then nausea and vomiting started. The next adverse reaction was that the man seemed lost and began to ignore all of his home environment.

A volunteer takes the Oxford University test.  Photo / AP

A volunteer takes the Oxford University test. Photo / AP

According to information in the Indian press, the patient was admitted to the Sri Ramachandra Hospital and Faculty of Medicine, where, after being released from the hospital, where he was admitted between October 11 and October 26. , he was reported to be “in an altered state of mind” and “disoriented.

The volunteer’s condition continued to worsen. According to information in the Indian press, he had to be transferred and urgently admitted to the hospital and the Sri Ramachandra Medical University.

In the medical establishment, they received him with “an altered mental state and very disoriented in time and space”. The volunteer was hospitalized between October 11 and 26, during this time they managed to stabilize him.

A healthcare worker prepares to test for COVID-19 in New Delhi.  Photo / Bloomber

A healthcare worker prepares to test for COVID-19 in New Delhi. Photo / Bloomber

Neurological disorders of the Indian volunteer

The patient’s wife said that after being released, she performed a series of neurological tests which confirmed considerable brain dysfunction. “He is slowly recovering and is better than he was, but he cannot work as before,” the volunteer’s wife told Indian media.

The laboratories’ response

Serum Institute of India is a manufacturer of immunobiological drugs, including vaccines, in the city of Pune, India, which was founded in 1966 by Cyrus Poonawalla.

Dr Ramakrishnan, principal investigator of the trial in India, was the person responsible for treating the patient who had brain damage. In communication with the main media in the Asian country, he said that the volunteer “is doing well now”.

Ramakrishnan added that the ethics committee of the establishment of the hospital where the patient was treated noted that the side effect was not due to the vaccine. However, it is so far unknown what produced it.

.

[ad_2]
Source link